Only two future events are certain – death, and disruption of the status quo

Introducing “Redefining Innovation: Embracing The 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry” There is a crisis of innovation for incumbents in the biopharmaceutical industry that should concern all of us. Once innovators who were responsible for some of the most significant advances in medical care the human race has seen, these organizations have 

Continue Reading…